Question 1

What is the share price of Nephrocare Health Services Ltd today?

Accepted Answer

Nephrocare Health Services Ltd (NEPHROPLUS) is trading at ₹596.45. The price shown is the latest available from the exchange feed and updates through the trading session.

Question 2

What is NEPHROPLUS’s P/E ratio versus the sector?

Accepted Answer

NEPHROPLUS trades at a P/E of —. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.

Question 3

What is NEPHROPLUS’s dividend yield?

Accepted Answer

NEPHROPLUS has a dividend yield of 0.00%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.

Question 4

What is NEPHROPLUS’s 52-week high and low?

Accepted Answer

NEPHROPLUS has traded between ₹446 and ₹781.5 over the past year. The Trading Data block shows where the current price sits inside that band.

Question 5

What is the market capitalisation of Nephrocare Health Services Ltd?

Accepted Answer

Nephrocare Health Services Ltd has a market capitalisation of ₹7,135 crore.

Question 6

What is NEPHROPLUS’s return on equity?

Accepted Answer

NEPHROPLUS reports a return on equity of -1.4%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in Medical Care Facilities.

Question 7

Who are NEPHROPLUS’s competitors?

Accepted Answer

The Peers block on this page lists other Medical Care Facilities companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.

Question 8

What is NEPHROPLUS’s promoter holding?

Accepted Answer

Promoters hold 63.85% of NEPHROPLUS. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.

Question 9

Which indices include NEPHROPLUS?

Accepted Answer

Index membership is listed in the Context block on this page, along with the weight NEPHROPLUS carries in each. That weight is what determines how much passive money tracks the stock.

Question 10

Is Nephrocare Health Services Ltd a good buy?

Accepted Answer

We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from NEPHROPLUS’s own numbers. The judgement is yours.

Revenue	₹630 crore
Net profit	-₹8 crore
Operating margin	14%
EPS	-₹0.8

NEPHROPLUS

NEPHROPLUS

Fundamental Strength Index

Profitability

Growth

Segment Results

Working Capital & Efficiency

NEPHROPLUS financial summary